Background: We studied the suitability of The Consortium to Establish a Registry for Alzheimer's Disease Neuropsychological Battery (CERAD-NB) total score for monitoring Alzheimer's disease (AD) progression in early-diagnosed medicated patients. We also investigated possible differences in progression between patients with very mild or mild baseline AD.

Methods: In this three-year follow-up of 115 ALSOVA study patients with clinical dementia ratings (CDR) of very mild (0.5) or mild (1) AD, we analyzed total CERAD-NB, Mini-Mental State Examination (MMSE), Neuropsychiatric Inventory (NPI), The Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory, and Clinical Dementia Rating Sum of Boxes scores. Correlations were identified with efficacy parameters.

Results: Over three years, total CERAD-NB declined significantly in both groups. Annual change rates of total CERAD-NB were also significant. Total CERAD-NB revealed annual differences in cognition between study groups, while MMSE did not. Total CERAD-NB correlated well with other cognitive and global measures, but not with NPI. For almost two years, the CDR-0.5 group maintained a higher activities of daily living than the CDR-1 group exhibited at baseline. Furthermore, the CDR-0.5 group showed milder neuropsychiatric symptoms at the end of follow-up than the CDR-1 group showed at baseline.

Conclusions: The CERAD total score is a suitable and sensitive follow-up tool in longitudinal AD trials. Cognition progression rates did not significantly differ between study groups; however, patients with very mild AD at baseline had milder neuropsychiatric symptoms after long-term follow-up. This emphasizes the importance of early diagnosis and assessment of neuropsychiatric symptoms at the diagnostic visit and during follow-up.

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1041610213000653DOI Listing

Publication Analysis

Top Keywords

total cerad-nb
20
alzheimer's disease
16
cerad-nb total
12
total score
12
neuropsychiatric symptoms
12
three-year follow-up
8
total
8
alsova study
8
patients mild
8
mild mild
8

Similar Publications

Background: Functional defects in eye movements and reduced reading speed in neurodegenerative diseases represent a potential new biomarker to support clinical diagnosis. We investigated whether computer-based eye-tracking (ET) analysis of the King-Devick (KD) test differentiates persons with idiopathic normal pressure hydrocephalus (iNPH) from cognitively unimpaired [control (CO)] and persons with Alzheimer's disease (AD).

Methods: We recruited 68 participants (37 CO, 10 iNPH, and 21 AD) who underwent neurological examination, the Consortium to Establish a Registry for Alzheimer's Disease neuropsychological test battery (CERAD-NB), and a Clinical Dementia Rating interview.

View Article and Find Full Text PDF

We aimed to evaluate the feasibility of using real-world register data for identifying persons with mild Alzheimer's disease (AD) and to describe their cognitive performance at the time of diagnosis. Patients diagnosed with AD during 2010-2013 (aged 60-81 years) were identified from the Finnish national health registers and enlarged with a smaller private sector sample (total  = 1,268). Patients with other disorders impacting cognition were excluded.

View Article and Find Full Text PDF

Background: Wide-ranging functional defects in eye movements have been reported in Alzheimer's disease (AD) dementia. The detection of abnormal eye movements and reading problems may identify persons at risk of AD when clear clinical symptoms are lacking.

Objective: To examine whether computer-based eye-tracking (ET) analysis of King-Devick (KD) test results differentiates cognitively healthy persons from persons with minor problems in cognitive testing or diagnosed mild AD.

View Article and Find Full Text PDF
Article Synopsis
  • The elderly population in Finland is experiencing changes in education and demographics, impacting cognitive screening for Alzheimer's disease (AD).
  • The study analyzed how education, age, and gender influence performance on the CERAD neuropsychological battery among patients with mild AD and at-risk controls.
  • Findings indicate that education is the strongest predictor of CERAD performance, and using education-adjusted cutoff scores significantly improves diagnostic accuracy between AD patients and controls.
View Article and Find Full Text PDF

Association of Sleep, Neuropsychological Performance, and Gray Matter Volume With Glymphatic Function in Community-Dwelling Older Adults.

Neurology

February 2022

From the Department of Medical Imaging and Intervention (T.Y.S., C.H.T.) and Neuroscience Research Center, Department of Neurology, Medical Center and College of Medicine (J.-L.H.), Chang Gung University College of Medicine, and Division of Acupuncture and Moxibustion, Department of Traditional Chinese Medicine (G.-H.L.), Department of Psychiatry (S.-H.L.), Department of Pulmonary and Critical Care Medicine (N.-H.C.), Biomedical Informatics Unit, Clinical Trial Center (C.J.F.), and Department of Nephrology (J.-T.F.), Chang Gung Memorial Hospital at Linkou, Taoyuan; Graduate Institute of Mind, Brain, & Consciousness (J.-L.H.), Taipei Medical University; Brain & Consciousness Research Center (J.-L.H.), Shuang Ho Hospital, New Taipei City; School of Traditional Chinese Medicine (G.-H.L., N.-H.C.) and School of Medicine (J.-T.F.), College of Medicine (S.-H.L.), Chang Gung University; Sleep Center (G.-H.L., N.-H.C.), Chang Gung Memorial Hospital, Taoyuan, Taiwan; and Department of Radiology (M.C.), University of North Carolina School of Medicine, Chapel Hill.

Background And Objectives: The glymphatic system, which is robustly enabled during some stages of sleep, is a fluid-transport pathway that clears cerebral waste products. Most contemporary knowledge regarding the glymphatic system is inferred from rodent experiments and human research is limited. Our objective is to explore the associations between human glymphatic function, sleep, neuropsychological performance, and cerebral gray matter volumes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!